These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
731 related articles for article (PubMed ID: 23786162)
1. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. Cui W; Zhang S; Shan C; Zhou L; Zhou Z FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162 [TBL] [Abstract][Full Text] [Related]
2. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells. Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor. Liu X; Li G Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770 [TBL] [Abstract][Full Text] [Related]
4. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469 [TBL] [Abstract][Full Text] [Related]
6. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Kefas B; Godlewski J; Comeau L; Li Y; Abounader R; Hawkinson M; Lee J; Fine H; Chiocca EA; Lawler S; Purow B Cancer Res; 2008 May; 68(10):3566-72. PubMed ID: 18483236 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470 [TBL] [Abstract][Full Text] [Related]
8. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643 [TBL] [Abstract][Full Text] [Related]
9. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA. Wang Y; Tang Q; Li M; Jiang S; Wang X Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162 [TBL] [Abstract][Full Text] [Related]
13. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation. Suto T; Yokobori T; Yajima R; Morita H; Fujii T; Yamaguchi S; Altan B; Tsutsumi S; Asao T; Kuwano H Carcinogenesis; 2015 Mar; 36(3):338-45. PubMed ID: 25503932 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Fang Y; Xue JL; Shen Q; Chen J; Tian L Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360 [TBL] [Abstract][Full Text] [Related]
17. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734 [TBL] [Abstract][Full Text] [Related]
18. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR. Wei W; Liu Y; Lu Y; Yang B; Tang L J Cell Biochem; 2017 Oct; 118(10):3349-3358. PubMed ID: 28295543 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance. Huynh FC; Jones FE PLoS One; 2014; 9(12):e114419. PubMed ID: 25532106 [TBL] [Abstract][Full Text] [Related]
20. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]